EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deciphering Lipid Metabolic Landscape of Sorafenib-Treated Hepatocellular Carcinoma by Mass Spectrometry Imaging and Transcriptomics

Dongsheng Li, Yuanyuan Tuo, Luheng Sai, Xiunan Xu, Fujuan Peng, Zhipeng Yan, Qin Yang, Huifang Zhao, Ruiping Zhang iD

Biomolecules · 02.05.2026 · 16 (5) · 675

DOI: 10.3390/biom16050675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 02.05.2026. Verfasst von Dongsheng Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical School, Shanxi Medical University, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Sorafenib, Carcinoma, Hepatocellular, Liver Neoplasms, Lipid Metabolism. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, National Natural Science Foundation of China, Science and Technology Department of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although sorafenib (SOR) is effective for advanced hepatocellular carcinoma (HCC), significant metabolic heterogeneity limits its therapeutic effect. In this study, we employed high-resolution matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) to profile the spatial lipidomic alterations in 3D HepG2 spheroids following SOR treatment. Interestingly, sphingophospholipid and glycerophospholipid metabolism played crucial roles. In an orthotopic HCC mouse model, immunohistochemical and immunofluorescence staining confirmed that SOR induced immunological and inflammatory changes. Moreover, transcriptomic and Q-PCR analyses showed increased expression of Stat1, Zbp1, Parp14, Irf1, and Tifa along with decreased Eif4e2 in the SOR treatment group compared to the tumor control group. Bio-layer interferometry and molecular docking data also indicated that ZBP1 possessed favorable binding affinities with SOR. Overall, our findings demonstrated that SOR dramatically disrupted sphingolipid metabolism in tumor cell spheroids and, in an orthotopic model, activated the NOD-like receptor signaling pathway, accompanied by altered secretion of inflammatory factors and macrophage polarization. These results suggest that SOR exerts dual effects on tumor cell lipid metabolism and the tumor immune microenvironment. These findings provide a conceptual basis for future exploration of lipid-modulating therapeutic strategies in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibCarcinoma, HepatocellularLiver NeoplasmsLipid MetabolismTranscriptomeAntineoplastic AgentsHumansAnimalsMiceHep G2 CellsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationMolecular Docking SimulationLipidomicsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

MALDI MSIhepatocellular carcinomalipid reprogrammingsorafenibtranscriptomics

Substanzen

SorafenibAntineoplastic Agents

Autor:innen und Institutionen

  • First Clinical Medical School, Shanxi Medical University, Taiyuan 030001, China.
  • School of Basic Medical Sciences, Academy of Medical Sciences, Research Institute of Circadian Rhythm and Disease, Shanxi Medical University, Taiyuan 030001, China.
  • Shanxi Provincial People's Hospital, Fifth Hospital of Shanxi Medical University, Taiyuan 030012, China.

ORCID-Profile: Ruiping Zhang

Förderung

  • Ministry of Science and Technology
  • National Natural Science Foundation of China
  • Science and Technology Department of Shanxi Province
  • Shanxi Medical University
  • Shanxi Provincial Department of Education
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Key R&D Program of China
  • Fundamental Research Program of Shanxi Province

Zitieren

APA

Li, D., Tuo, Y., Sai, L., Xu, X., Peng, F., Yan, Z., Yang, Q., Zhao, H., & Zhang, R. (2026). Deciphering Lipid Metabolic Landscape of Sorafenib-Treated Hepatocellular Carcinoma by Mass Spectrometry Imaging and Transcriptomics. Biomolecules, 16(5), 675. https://doi.org/10.3390/biom16050675

Vancouver

Li D, Tuo Y, Sai L, Xu X, Peng F, Yan Z, et al. Deciphering Lipid Metabolic Landscape of Sorafenib-Treated Hepatocellular Carcinoma by Mass Spectrometry Imaging and Transcriptomics. Biomolecules. 2026;16(5):675. doi:10.3390/biom16050675

BibTeX
@article{Li2026,
  author = {Li, Dongsheng and Tuo, Yuanyuan and Sai, Luheng and Xu, Xiunan and Peng, Fujuan and Yan, Zhipeng and Yang, Qin and Zhao, Huifang and Zhang, Ruiping},
  title = {Deciphering Lipid Metabolic Landscape of Sorafenib-Treated Hepatocellular Carcinoma by Mass Spectrometry Imaging and Transcriptomics},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {675},
  doi = {10.3390/biom16050675}
}
Kostenlos starten →